iShares Russell 1000 Growth ETF Could Be Headed For $189
ETF Channel | May 05, 2020 08:17AM ET
For the iShares Russell 1000 Growth ETF (NYSE:IWF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $188.55 per unit. With IWF trading at a recent price near $169.68 per unit, that means that analysts see 11.12% upside for this ETF looking through to the average analyst targets of the underlying holdings.
Three of IWF's underlying holdings with notable upside to their analyst target prices are PRA Health Sciences (NASDAQ:PRAH), Teradata Corp (NYSE:TDC), and Hill-Rom (NYSE:HRC). Although PRAH has traded at a recent price of $86.64/share, the average analyst target is 19.60% higher at $103.62/share. Similarly, TDC has 18.30% upside from the recent share price of $23.14 if the average analyst target price of $27.38/share is reached, and analysts on average are expecting HRC to reach a target price of $124.12/share, which is 17.30% above the recent price of $105.82. Below is a twelve-month price history chart comparing the stock performance of PRAH, TDC, and HRC:
Below is a summary table of the current analyst target prices discussed above:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target (NYSE:TGT) | % Upside to Target |
|---|---|---|---|---|
| iShares Russell 1000 Growth ETF | IWF | $169.68 | $188.55 | 11.12% |
| PRA Health Sciences Inc | PRAH | $86.64 | $103.62 | 19.60% |
| Teradata Corp | TDC | $23.14 | $27.38 | 18.30% |
| Hill-Rom Holdings, Inc. | HRC | $105.82 | $124.12 | 17.30% |
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.